Skip to main content
. 2021 Nov 24;24(3):513–525. doi: 10.1002/ejhf.2381

Figure 1.

EJHF-2381-FIG-0001-c

Effects of dapagliflozin compared with placebo on clinical events according to atrial fibrillation (AF) status at baseline. All hazard ratios are adjusted for history of heart failure hospitalization (apart from all‐cause death) and stratified by diabetes status. CI, confidence interval; ECG, electrocardiogram.